Yoshihide Sehara
Shimotsuke, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Correction: Post-ischemic modification of neurogenesis and oligodendrogenesis in rodent models.
Journal: Frontiers in neural circuits
Published: April 23, 2026
Post-ischemic modification of neurogenesis and oligodendrogenesis in rodent models.
Journal: Frontiers in neural circuits
Published: February 03, 2026
AAV9/hGLA gene therapy reduces podocyte GL-3 accumulation in a Fabry disease mouse model.
Journal: Molecular genetics and metabolism
Published: January 24, 2026
Limitation of Assay Sensitivity Revealed by the Improvement of Cell-Based Assay Against Various Adeno-Associated Virus Serotypes.
Journal: Human gene therapy
Published: May 19, 2025
Therapeutic Strategy for Fabry Disease by Intravenous Administration of Adeno-Associated Virus 9 in a Symptomatic Mouse Model.
Journal: Human gene therapy
Published: February 22, 2024
Adeno-associated Virus-mediated Ezh2 Knockdown Reduced the Increment of Newborn Neurons Induced by Forebrain Ischemia in Gerbil Dentate Gyrus.
Journal: Molecular neurobiology
Published: January 26, 2024
Therapeutic strategy for Fabry disease by intravenous administration of adeno-associated virus 2 or 9 in α-galactosidase A-deficient mice.
Journal: The journal of gene medicine
Published: July 29, 2022
Resection of Gastric Cancer Remitted Anti-signal Recognition Particle Myopathy.
Journal: Internal medicine (Tokyo, Japan)
Published: February 03, 2022
Higher Transduction Efficiency of AAV5 to Neural Stem Cells and Immature Neurons in Gerbil Dentate Gyrus Compared to AAV2 and rh10.
Journal: Human gene therapy
Published: August 05, 2021
Tapia Syndrome after Endotracheal Intubation in General Anesthesia.
Journal: Internal medicine (Tokyo, Japan)
Published: July 28, 2020
Last Updated: 09/26/2026